Rose-Hulman Ventures

07/24/2020

From cybersecurity to health care, Ventures business partners are often at the forefront of combating national and global challenges.

eRAMx, a long-time Ventures partner, is no exception. The Evansville, Indiana-based company is focused on remote medication monitoring for the sole purpose of improving participant health outcomes.

Read more:

Ventures partner eRAMx is looking to make a big impact with the use of a proprietary telehealth remote medication monitoring app

04/01/2017

We are very proud to play a role in this project!

12/15/2016

It was a very good year!
This year was one of game-changing innovation for our clients, and we were honored to help them bring their concepts to fruition. In the spirit of giving, we wanted to share a few highlights from an extraordinary year—without giving away any trade secrets! http://ow.ly/ek78307al8N

10/26/2016

This supersized 3D printer is the brainchild of 3D Platform (3DP), a leading manufacturer of industrial 3D printer machines based in Roscoe, Illinois. The company’s leadership includes father-and-son Rose-Hulman alumni Robert Schroeder (chief executive officer) and Jonathan Schroeder (president). They turned to Rose-Hulman Ventures when an opportunity unexpectedly presented itself this summer for the company to occupy a key spot at the September International Manufacturing Technology Show in Chicago, giving them just 60 days to complete the project.
Read more: http://ow.ly/V0RC305z0JO

Project managers, technicians, and student interns completed a large-scale 3D printer in just two months for 3D Platform. The printer was a highlight of the 2016 International Manufacturing Technology Show in Chicago.

10/14/2016

Wonderful article from Inside Indiana Business

A young Indianapolis-based company says it’s giving stroke victims new hope. NICO Corporation created a tool several years ago to access the brain, namely to remove tumors, but is now applying the ...

09/06/2016

Rose-Hulman Ventures is helping a medical startup break new ground in the fight against sudden fatal heart attacks, a leading cause of death in the United States.
Arrhythmotech LLC is pioneering new, noninvasive technology to simultaneously record and process both sympathetic nerve activity and electrocardiogram signals. Their work could help doctors better identify patients at risk of sudden fatal heart attacks, according to Dr. Peng-Sheng Chen, co-founder of the company.
Read more here: http://ow.ly/eCw1303WVyc